Highly effective artemisinin-based antimalarial drugs are used worldwide and have contributed to reductions in the malaria burden in many areas. Artemisinin-resistant Plasmodium falciparum malaria has emerged in western Cambodia and its potential spread threatens to reverse recent gains against malaria and to abort plans for a renewed global eradication campaign. Ongoing efforts to contain artemisinin-resistant malaria are hampered by the lack of tools to gauge the extent and direction of its spread. Presently, only laborious clinical trials can reliably measure resistance. A molecular assay to detect markers of artemisinin resistance would be a highly valuable surveillance tool, but the genetic basis of resistance is unknown. We propose genome-wide association studies (GWAS) that aim to identify molecular markers that can be used to track and contain artemisinin-resistant parasites before they spread globally. The work will be accomplished in two aims. First, we will use a dense panel of single nucleotide polymorphisms (SNPs) to map regions of the P. falciparum genome that are associated with artemisinin resistance. To accomplish this, we will use an established SNP- calling pipeline to determine genotypes at ~421,000 SNPs from short-read sequencing data in parasites collected during completed trials of artemisinin efficacy, and we will estimate the association between parasite genotypes and the amount of time it takes to reduce parasitemia by half following artemisinin treatment (i.e. parasite clearance half-life). Associations will be estimated in two independent sample sets, and meta-analysis will be performed to validate genomic regions associated with artemisinin resistance. In the second aim, we will identify and prioritize candidate genes within genomic regions identified in Aim 1 and use next-generation sequencing data to identify polymorphisms within high-priority genes and their association with parasite clearance half-life. If successful, this project will result in the development of a rapid assay to detect candidate markers of artemisinin resistance in subsequent candidate gene association studies, as well as data to begin the functional characterization of candidate genes to better understand the mechanisms underlying resistance.

Public Health Relevance

The most important class of drugs for malaria, the artemisinins, is threatened by the recent emergence of artemisinin-resistant malaria parasites. Since most malaria-endemic countries use artemisinins to treat malaria, the spread of artemisinin-resistant parasites could result in th inability to successfully treat this devastating disease. This project aims to identify parasite genes underlying artemisinin resistance, in an effort to develop tools to track resistant parasites and contain them before they spread globally.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Research Project (R01)
Project #
Application #
Study Section
Genetic Variation and Evolution Study Section (GVE)
Program Officer
Joy, Deirdre A
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Maryland Baltimore
Internal Medicine/Medicine
Schools of Medicine
United States
Zip Code
Zuber, Janie Anne; Takala-Harrison, Shannon (2018) Multidrug-resistant malaria and the impact of mass drug administration. Infect Drug Resist 11:299-306
Lin, Jessica T; Patel, Jaymin C; Levitz, Lauren et al. (2018) Gametocyte Carriage, Antimalarial Use, and Drug Resistance in Cambodia, 2008-2014. Am J Trop Med Hyg 99:1145-1149
Agrawal, Sonia; Moser, Kara A; Morton, Lindsay et al. (2017) Association of a Novel Mutation in the Plasmodium falciparum Chloroquine Resistance Transporter With Decreased Piperaquine Sensitivity. J Infect Dis 216:468-476
Grist, Eric P M; Flegg, Jennifer A; Humphreys, Georgina et al. (2016) Optimal health and disease management using spatial uncertainty: a geographic characterization of emergent artemisinin-resistant Plasmodium falciparum distributions in Southeast Asia. Int J Health Geogr 15:37
MalariaGEN Plasmodium falciparum Community Project (2016) Genomic epidemiology of artemisinin resistant malaria. Elife 5:
Takala-Harrison, Shannon; Laufer, Miriam K (2015) Antimalarial drug resistance in Africa: key lessons for the future. Ann N Y Acad Sci 1342:62-7
Travassos, Mark A; Coulibaly, Drissa; Bailey, Jason A et al. (2015) Differential recognition of terminal extracellular Plasmodium falciparum VAR2CSA domains by sera from multigravid, malaria-exposed Malian women. Am J Trop Med Hyg 92:1190-4
Artimovich, Elena; Schneider, Kristan; Taylor, Terrie E et al. (2015) Persistence of Sulfadoxine-Pyrimethamine Resistance Despite Reduction of Drug Pressure in Malawi. J Infect Dis 212:694-701
Takala-Harrison, Shannon; Jacob, Christopher G; Arze, Cesar et al. (2015) Independent emergence of artemisinin resistance mutations among Plasmodium falciparum in Southeast Asia. J Infect Dis 211:670-9
Miotto, Olivo; Amato, Roberto; Ashley, Elizabeth A et al. (2015) Genetic architecture of artemisinin-resistant Plasmodium falciparum. Nat Genet 47:226-34

Showing the most recent 10 out of 19 publications